Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
2006 1
2007 1
2008 1
2009 1
2010 1
2011 9
2012 5
2013 8
2014 8
2015 3
2016 4
2017 9
2018 8
2019 9
2020 7
2021 15
2022 5
2023 17
2024 4

Text availability

Article attribute

Article type

Publication date

Search Results

102 results

Results by year

Filters applied: . Clear all
Page 1
Selective PDE4 subtype inhibition provides new opportunities to intervene in neuroinflammatory versus myelin damaging hallmarks of multiple sclerosis.
Schepers M, Paes D, Tiane A, Rombaut B, Piccart E, van Veggel L, Gervois P, Wolfs E, Lambrichts I, Brullo C, Bruno O, Fedele E, Ricciarelli R, Ffrench-Constant C, Bechler ME, van Schaik P, Baron W, Lefevere E, Wasner K, Grünewald A, Verfaillie C, Baeten P, Broux B, Wieringa P, Hellings N, Prickaerts J, Vanmierlo T. Schepers M, et al. Among authors: vanmierlo t. Brain Behav Immun. 2023 Mar;109:1-22. doi: 10.1016/j.bbi.2022.12.020. Epub 2022 Dec 28. Brain Behav Immun. 2023. PMID: 36584795 Free article.
From OPC to Oligodendrocyte: An Epigenetic Journey.
Tiane A, Schepers M, Rombaut B, Hupperts R, Prickaerts J, Hellings N, van den Hove D, Vanmierlo T. Tiane A, et al. Among authors: vanmierlo t. Cells. 2019 Oct 11;8(10):1236. doi: 10.3390/cells8101236. Cells. 2019. PMID: 31614602 Free PMC article. Review.
Phosphodiesterase Type 4 Inhibition in CNS Diseases.
Blokland A, Heckman P, Vanmierlo T, Schreiber R, Paes D, Prickaerts J. Blokland A, et al. Among authors: vanmierlo t. Trends Pharmacol Sci. 2019 Dec;40(12):971-985. doi: 10.1016/j.tips.2019.10.006. Epub 2019 Nov 5. Trends Pharmacol Sci. 2019. PMID: 31704172 Review.
Hypoxic oligodendrocyte precursor cell-derived VEGFA is associated with blood-brain barrier impairment.
Manukjan N, Majcher D, Leenders P, Caiment F, van Herwijnen M, Smeets HJ, Suidgeest E, van der Weerd L, Vanmierlo T, Jansen JFA, Backes WH, van Oostenbrugge RJ, Staals J, Fulton D, Ahmed Z, Blankesteijn WM, Foulquier S. Manukjan N, et al. Among authors: vanmierlo t. Acta Neuropathol Commun. 2023 Aug 7;11(1):128. doi: 10.1186/s40478-023-01627-5. Acta Neuropathol Commun. 2023. PMID: 37550790 Free PMC article.
From methylation to myelination: epigenomic and transcriptomic profiling of chronic inactive demyelinated multiple sclerosis lesions.
Tiane A, Schepers M, Reijnders RA, van Veggel L, Chenine S, Rombaut B, Dempster E, Verfaillie C, Wasner K, Grünewald A, Prickaerts J, Pishva E, Hellings N, van den Hove D, Vanmierlo T. Tiane A, et al. Among authors: vanmierlo t. Acta Neuropathol. 2023 Aug;146(2):283-299. doi: 10.1007/s00401-023-02596-8. Epub 2023 Jun 7. Acta Neuropathol. 2023. PMID: 37286732 Free PMC article.
102 results